Published Online
on August 23, 2004

A more recent version of this article appeared on August 31, 2004

This Article Full Text (PDF) All Versions of this Article: 110/9/1140    most recent 01.CIR.0000139851.50067.E4v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Muzaffar, S. Articles by Jeremy, J. Y. Search for Related Content PubMed PubMed Citation Articles by Muzaffar, S. Articles by Jeremy, J. Y. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ACETYLSALICYLIC ACID NITRIC OXIDE Related Collections Pathophysiology Pulmonary circulation and disease Oxidant stress Endothelium/vascular type/nitric oxide

Submitted on May 1, 2003
Revised on March 18, 2004
Accepted on March 24, 2004

Nitroaspirins and Morpholinosydnonimine but Not Aspirin Inhibit the Formation of Superoxide and the Expression of gp91^phox Induced by Endotoxin and Cytokines in Pig Pulmonary Artery Vascular Smooth Muscle Cells and Endothelial Cells

Saima Muzaffar PhD, Nilima Shukla PhD, Gianni Angelini FRCS, and Jamie Y. Jeremy PhD^*

From the Bristol Heart Institute, University of Bristol, Bristol, UK.

^* To whom correspondence should be addressed. E-mail: j.y.jeremy{at}bris.ac.uk.

Background--Although nonsteroidal antiinflammatory drugs (NSAIDs) are ineffective in treating acute respiratory distress syndrome (ARDS), inhalational NO has proved to be useful. NO-donating NSAIDs may therefore be more effective in treating ARDS than NSAIDs alone. Because oxidant stress is central to the pathophysiology of ARDS, the effect of nitroaspirins (NCX 4016, NCX 4040, and NCX 4050) compared with morpholinosydnonimine (SIN-1; an NO donor) and aspirin (ASA) on superoxide (O₂^·-) formation and gp91^phox (an active catalytic subunit of NADPH oxidase) expression in pig pulmonary artery vascular smooth muscle cells (PAVSMCs) and endothelial cells (PAECs) was investigated.

Methods and Results--Cultured PAVSMCs and PAECs were incubated with lipopolysaccharide (LPS), tumor necrosis factor (TNF)-, and interleukin (IL)-1 (with or without NO-ASA, SIN-1, or ASA) for 16 hours, and O₂^·- release was measured by use of the reduction of ferricytochrome c. The expression of gp91^phox was assessed by use of Western blotting. LPS, TNF-, and IL-1 all stimulated the formation of O₂^·- and expression of gp91^phox in both PAVSMCs and PAECs, an effect inhibited by NADPH oxidase inhibitors, diphenyleneiodonium, and apocynin. SIN-1, NCX 4016, and NCX 4050 but not ASA alone inhibited the formation of O₂^·- and expression of gp91^phox.

Conclusions--LPS and cytokines promote the formation of O₂^·- in PAVSMCs and PAECs through an augmentation of NADPH oxidase activity, which in turn is prevented by NO. Thus, NO may play a protective role in preventing excess O₂^·- formation, but its negation by O₂^·- may augment the progress of ARDS. The inhibitory effect of nitroaspirins suggests that they may be therapeutically useful in treating ARDS through the suppression of NADPH oxidase upregulation and O₂^·- formation.

Key words: superoxides • NADPH oxidase • nitric oxide • respiratory distress syndrome, adult • pulmonary artery

This article has been cited by other articles:

				Abstracts Heart, February 1, 2009; 95(4): e1 - e1. [Full Text] [PDF]

				Y.-L. Li, Y. Ding, C. Agnew, and H. D. Schultz Exercise training improves peripheral chemoreflex function in heart failure rabbits J Appl Physiol, September 1, 2008; 105(3): 782 - 790. [Abstract] [Full Text] [PDF]

				S. Wan, N. Shukla, G. D. Angelini, A. P.C. Yim, J. L. Johnson, and J. Y. Jeremy Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: A comparison with aspirin and morpholinosydnonimine (SIN-1). J. Thorac. Cardiovasc. Surg., October 1, 2007; 134(4): 1033 - 1039. [Abstract] [Full Text] [PDF]

				C. E. Teixeira, F. B. M. Priviero, and R. C. Webb Effects of 5-Cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine (BAY 41-2272) on Smooth Muscle Tone, Soluble Guanylyl Cyclase Activity, and NADPH Oxidase Activity/Expression in Corpus Cavernosum from Wild-Type, Neuronal, and Endothelial Nitric-Oxide Synthase Null Mice J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1093 - 1102. [Abstract] [Full Text] [PDF]

				S. Selemidis, G. J. Dusting, H. Peshavariya, B. K. Kemp-Harper, and G. R. Drummond Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells Cardiovasc Res, July 15, 2007; 75(2): 349 - 358. [Abstract] [Full Text] [PDF]

				X. Fu, D. G. Beer, J. Behar, J. Wands, D. Lambeth, and W. Cao cAMP-response Element-binding Protein Mediates Acid-induced NADPH Oxidase NOX5-S Expression in Barrett Esophageal Adenocarcinoma Cells J. Biol. Chem., July 21, 2006; 281(29): 20368 - 20382. [Abstract] [Full Text] [PDF]

				S Muzaffar, N Shukla, G D Angelini, and J Y Jeremy Acute hypoxia simultaneously induces the expression of gp91phox and endothelial nitric oxide synthase in the porcine pulmonary artery Thorax, April 1, 2005; 60(4): 305 - 313. [Abstract] [Full Text] [PDF]